Advertisement

Topics

March 2018 Briefing - Hematology & Oncology

00:15 EDT 2 Apr 2018 | Drugs.com

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for March 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...

Original Article: March 2018 Briefing - Hematology & Oncology

NEXT ARTICLE

More From BioPortfolio on "March 2018 Briefing - Hematology & Oncology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...